Skip to content
10-K

Annual Report

Eloxx Pharmaceuticals, Inc. ELOX

0001193125-26-108687

← back to feed
Filed
Mar 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 12, 2026 5.07M sh
Shares Diluted FY 2025 · Dec 31, 2025 12.35M sh
Shares Diluted FY 2025 · Dec 31, 2024 3.76M sh
Shares Diluted FY 2025 · Dec 31, 2023 2.57M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$6.33M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$4.72M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$14.34M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $0
Long Term Debt FY 2025 · Dec 31, 2023 $1.61M
Short Term Debt FY 2025 · Dec 31, 2025 $1M
Short Term Debt FY 2025 · Dec 31, 2024 $6.52M
Short Term Debt FY 2025 · Dec 31, 2023 $2.22M
Cash And Equivalents FY 2025 · Dec 31, 2025 $4.79M
Cash And Equivalents FY 2025 · Dec 31, 2024 $111K
Cash And Equivalents FY 2025 · Dec 31, 2023 $1.13M
Stockholders Equity FY 2025 · Dec 31, 2025 −$11.91M
Stockholders Equity FY 2025 · Dec 31, 2024 −$24.34M
Stockholders Equity FY 2025 · Dec 31, 2023 −$22.6M
Stockholders Equity FY 2025 · Dec 31, 2022 −$10.66M
Current Liabilities FY 2025 · Dec 31, 2025 $17.18M
Current Liabilities FY 2025 · Dec 31, 2024 $27.31M
Current Liabilities FY 2025 · Dec 31, 2023 $22.7M
Total Liabilities FY 2025 · Dec 31, 2025 $17.18M
Total Liabilities FY 2025 · Dec 31, 2024 $27.31M
Total Liabilities FY 2025 · Dec 31, 2023 $24.31M
Current Assets FY 2025 · Dec 31, 2025 $5.27M
Current Assets FY 2025 · Dec 31, 2024 $2.98M
Current Assets FY 2025 · Dec 31, 2023 $1.55M
Total Assets FY 2025 · Dec 31, 2025 $5.27M
Total Assets FY 2025 · Dec 31, 2024 $2.98M
Total Assets FY 2025 · Dec 31, 2023 $1.71M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.49
Eps Diluted FY 2025 · Dec 31, 2024 −$0.84
Eps Diluted FY 2025 · Dec 31, 2023 −$6.63
Eps Basic FY 2025 · Dec 31, 2025 −$0.49
Eps Basic FY 2025 · Dec 31, 2024 −$0.84
Eps Basic FY 2025 · Dec 31, 2023 −$6.63
Sga Expense FY 2025 · Dec 31, 2025 $3.38M
Sga Expense FY 2025 · Dec 31, 2024 $5.25M
Sga Expense FY 2025 · Dec 31, 2023 $8.69M
Net Income FY 2025 · Dec 31, 2025 −$6M
Net Income FY 2025 · Dec 31, 2024 −$3.14M
Net Income FY 2025 · Dec 31, 2023 −$17.05M
Operating Income FY 2025 · Dec 31, 2025 −$6.44M
Operating Income FY 2025 · Dec 31, 2024 −$2.47M
Operating Income FY 2025 · Dec 31, 2023 −$17.29M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $6.36M
Revenue FY 2025 · Dec 31, 2023 $0